AEMD - Company ID 0000882291
The table below shows AETHLON MEDICAL INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | - | - | $0.00 | $574.25K | $294.17K | $659.10K |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $1.91M | $2.21M | $2.52M | $2.75M | $2.34M | $2.07M |
| SG&A |
AETHLON MEDICAL INC reported annual revenue of $0.00 for fiscal year 2024. That is down 100.0% from $574.25K in fiscal 2023. Over the 10 fiscal years shown, annual revenue declined from $762.42K (FY 2015) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.70M |
| $3.24M |
| $3.90M |
| $4.48M |
| $3.46M |
| $2.46M |
| Operating income | -$7.29M | -$9.34M | -$12.64M | -$11.90M | -$10.42M | -$7.89M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$7.15M | -$13.39M | -$12.21M | -$12.03M | -$10.42M | -$7.89M |
| EPS (diluted) | -$10.61 | -$8.58 | -$38.87 | -$5.86 | -$0.71 | - |